Diagnosis and Management
This patient has CEAP C2-3 chronic venous disease with saphenofemoral junction incompetence and great saphenous vein insufficiency requiring endovenous thermal ablation (radiofrequency or laser) of the GSV, combined with phlebectomy of varicose tributaries, rather than compression therapy alone. 1
Clinical Classification
Based on the Doppler findings, this represents:
- CEAP Classification: C2-3 (varicose veins with minimal edema), Ep (primary etiology), As (superficial veins), Pr (reflux) 2
- Anatomic involvement: Incompetent saphenofemoral junction, prominent great saphenous vein with tributary varicosities, and three incompetent perforators
- Deep system: Normal and competent (no DVT, normal flow patterns)
Treatment Algorithm
Primary Intervention: GSV Ablation
Endovenous thermal ablation (RFA or EVLA) is the recommended first-line treatment over traditional high ligation and stripping 1. The evidence shows:
- Technical success rates are comparable between RFA and EVLA up to 5 years (moderate-certainty evidence), though RFA may offer superior long-term outcomes beyond 5 years with lower recurrence rates 3
- Both thermal ablation techniques demonstrate superior technical success compared to foam sclerotherapy, particularly in long-term follow-up 3
- Avoid compression therapy as primary treatment when the patient is a candidate for saphenous ablation (strong recommendation) 1
Adjunctive Procedures
Phlebectomy or sclerotherapy should be performed to treat the varicose tributaries identified along the medial leg 1. This addresses the visible varicosities and reduces symptom burden.
Management of Incompetent Perforators
Do NOT routinely treat the three incompetent perforators in this C2-3 patient 1. The guidelines specifically recommend against selective perforator treatment in simple varicose veins (CEAP C2). Perforator intervention is only suggested for:
- Pathologic perforators (outward flow ≥500 ms, diameter ≥3.5 mm)
- Located underneath healed or active ulcers (CEAP C5-6)
This patient has neither criterion. Evidence shows that incompetent perforators often persist after GSV treatment but do not significantly impact clinical outcomes or quality of life at 1-year follow-up in non-ulcerated patients 4.
Key Clinical Considerations
Factors Supporting Ablation Decision
The decision for GSV ablation rather than preservation is supported by:
- Saphenofemoral junction incompetence with reflux on Valsalva
- Prominent GSV caliber throughout thigh and leg
- Multiple tributary varicosities indicating significant hemodynamic burden
- Presence of soft tissue edema (progression to C3)
Expected Outcomes
Post-ablation duplex findings at 2 years typically show 5:
- GSV truncal occlusion in 90% of cases
- Open, competent saphenofemoral junction with short patent terminal segment conducting prograde flow (82%)
- Low rates of saphenofemoral junction reflux (approximately 8%)
- Minimal neovascularity in the groin
- Symptom improvement in 95% of patients
Common Pitfalls to Avoid
- Do not perform compression therapy alone as definitive treatment when ablation is feasible—this delays appropriate intervention 1
- Do not add SEPS (subfascial endoscopic perforator surgery) for the incompetent perforators in this C2-3 patient—it adds no clinical benefit at this stage 4
- Do not use foam sclerotherapy as primary GSV treatment—it has inferior technical success rates compared to thermal ablation, particularly long-term 3
Post-Procedure Management
After thermal ablation and phlebectomy:
- Short-term compression (typically 1-2 weeks) to reduce post-procedure discomfort
- Early mobilization
- Duplex surveillance at appropriate intervals to assess for recurrence
- Monitor for resolution of edema
The recurrence rate after proper thermal ablation is 15-35% at 2 years 2, significantly lower than historical surgical stripping rates, with most recurrences related to neovascularization or incompetent tributaries rather than technical failure 5.